Treatment GuideJust DiagnosedSex & DatingAfrican AmericanStigmaAsk the HIV DocPrEP En EspañolNewsVoicesPrint IssueVideoOut 100
CONTACTCAREER OPPORTUNITIESADVERTISE WITH USPRIVACY POLICYPRIVACY PREFERENCESTERMS OF USELEGAL NOTICE
© 2024 Pride Publishing Inc.
All Rights reserved
All Rights reserved
By continuing to use our site, you agree to our Private Policy and Terms of Use.
The Food and Drug Administration has approved dosing recommendations for Norvir in pediatric patients ages 1 month to 2 years. The recommended dosage is 350 to 400 milligrams twice daily, beginning at 250 milligrams twice per day and increased in 50-milligram increments every two to three days until full dosing levels are reached. Switching from Combivir to Truvada results in a significantly lower virus concentration after six months, according to a study by Gilead Sciences. Patients taking Truvada also experienced increased levels of hemoglobin, which is usually reduced by HIV. A study of 167 treatment-experienced HIV-positive adults has shown that Kaletra maintains durable HIV suppression and increased CD4-cell counts over four years of therapy. The study authors say their results support the use of Kaletra as part of salvage regimens. Results from a 48-week clinical trial have shown that roughly 30% of patients with drug-resistant virus achieved a decrease in HIV viral levels to below 400 copies per milliliter of blood when taking Ritonavir-boosted Aptivus, compared to almost 14% of patients taking other Ritonavir-boosted protease inhibitors. Two key studies of HIV entry inhibitors have been called off because of toxicity issues and poor study results. Pharmaceutical maker GlaxoSmithKline ended Phase III trials of its experimental CCR5 inhibitor aplaviroc after three study subjects developed severe liver toxicity. Schering Plough halted its Phase II study of CCR5 inhibitor vicriviroc when study data showed early viral rebound. Tibotec Therapeutics has expanded access to its experimental protease inhibitor TMC114 after early tests showed the drug is effective against HIV that is resistant to other protease drugs. The colorectal cancer treatment Campto (irinotecan) is effective in treating Kaposi's sarcoma, according to a study that was published in the November 4 edition of the journal AIDS. Researchers found that three quarters of study subjects treated with Campto experienced complete or partial KS remission. Pegylated liposomal doxorubicin used in combination with antiretroviral medications is effective in treating Kaposi's sarcoma, researchers reported in the journal Infection. Nearly 82% of study subjects reported complete or partial KS remission within a median of eight weeks of treatment.
Want more breaking equality news & trending entertainment stories?
Check out our NEW 24/7 streaming service: the Advocate Channel!
Download the Advocate Channel App for your mobile phone and your favorite streaming device!
From our Sponsors
Most Popular
Before AIDS, gay artist Rex drew hot men on the prowl — then he disappeared
April 11 2024 3:15 PM
Diets that mimic fasting reverse aging: study
March 07 2024 5:28 PM
PrEP without a prescription now a reality in California
February 06 2024 8:37 PM
Injectable HIV treatment, prevention: Everything you need to know
March 26 2024 3:28 PM
8 dating tips for gay men from a gay therapist
March 21 2024 2:50 PM
Happy national foreskin day!
April 04 2024 1:45 PM
The science behind U=U has been liberating people with HIV for years
June 04 2024 3:31 PM
Scarlet fever: exploring our fascination with blood
March 13 2024 1:47 PM
On Anal Sex Day, crack up with The Bottom's Digest
April 18 2024 10:22 AM
Plus: Featured Video
Latest Stories
Activist and philanthropist Bruce Bastian dies at 76
June 26 2024 1:28 PM
Yes, HIV-positive people can safely breastfeed
June 26 2024 12:59 PM
Exclusive: We kiki with Q from 'RuPaul's Drag Race'
June 24 2024 11:37 AM
Court rules to keep PrEP coverage under Obamacare
June 21 2024 5:42 PM
In honor of Juneteenth 2024, meet The Normal Anomaly
June 19 2024 1:39 PM
What is Juneteenth?
June 19 2024 11:30 AM
As Pride party season begins, the CDC urges mpox vaccinations
May 16 2024 6:52 PM
Advocacy in action with AIDSWatch
May 09 2024 12:30 PM
The Talk: Thriving with HIV
May 08 2024 10:45 AM
The Talk: What HIV isn’t
May 07 2024 10:48 AM
The Talk: Finding balance with HIV
May 06 2024 10:51 AM
Justice Dept plans to reschedule marijuana as a lower-risk drug
May 03 2024 2:40 PM
The Talk: Starting your journey with HIV
May 03 2024 2:00 PM
Why is a mother’s mental health so important? A doctor explains
May 01 2024 1:38 PM
Walmart to close all of its health care clinics
April 30 2024 12:30 PM
Vampire facial spa infected several women with HIV
April 29 2024 7:26 PM